The Rationale for Potential Pharmacotherapy of COVID-19

MLA

Maha Saber-Ayad, et al. “The Rationale for Potential Pharmacotherapy of COVID-19.” Pharmaceuticals, vol. 13, no. 5, May 2020, p. 96. EBSCOhost, https://doi.org/10.3390/ph13050096.

APA

Maha Saber-Ayad, Mohamed A. Saleh, & Eman Abu-Gharbieh. (2020). The Rationale for Potential Pharmacotherapy of COVID-19. Pharmaceuticals, 13(5), 96. https://doi.org/10.3390/ph13050096

Chicago

Maha Saber-Ayad, Mohamed A. Saleh, and Eman Abu-Gharbieh. 2020. “The Rationale for Potential Pharmacotherapy of COVID-19.” Pharmaceuticals 13 (5): 96. doi:10.3390/ph13050096.